Events

January 2020

February 2020

January 2020

Expanding AAV Manufacturing Capacity for Rare Disease Gene Therapies

Jan. 28–29, 2020
8 a.m. to 5 p.m. ET

National Institutes of Health (Main Campus)
Natcher Conference Center (Bldg. 45), Ruth L. Kirschstein Auditorium
45 Center Drive
Bethesda, Maryland 20892

Current adeno-associated virus (AAV) manufacturing capacity cannot keep pace with the demand for AAV gene therapy clinical trials. NCATS and the Center for Biologics Evaluation and Research (CBER) at the Food and Drug Administration (FDA) will host a workshop on the NIH main campus on January 28–29 to explore obstacles and identify opportunities for expanding the capacity of AAV manufacturing.

Website • RegistrationSubmit Abstracts • Videocast

February 2020

Rare Disease Day at NIH

Feb. 28, 2020
8:30 a.m. to 4:30 p.m. ET

National Institutes of Health (Main Campus)
Natcher Conference Center (Bldg. 45)
45 Center Drive
Bethesda, Maryland 20892

Sponsored by the National Center for Advancing Translational Sciences (NCATS) and Clinical Center (CC) at the National Institutes of Health (NIH), Rare Disease Day at NIH aims to raise awareness about rare diseases, the people they affect, and NIH research collaborations under way to address scientific challenges and to advance new treatments.

Admission is free, and the event is open to the public, including patients, patient advocates, health care providers, researchers, industry representatives and government employees. In association with Global Genes®, participants are encouraged to wear their favorite pair of jeans.

RegistrationVideocast